{"ticker": {"uuid": "59e98105-9bab-416f-8854-94c75e42afe2", "symbol": "GALD", "name": "GALDERMA GROUP N", "exchange": "EBS", "country": "CH", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "Galderma Receives European Union Approval for Restylane\u00ae Shaype\u2122: the First-and-Only Bone-Mimicking Hyaluronic Acid Injectable for Facial Shaping", "summary": "Galderma has introduced the first-and-only shaper to the hyaluronic acid (HA) market with Restylane Shaype, now approved in the European Union (EU) for chin augmentation1 Restylane Shaype is the firmest HA gel available, powered by new NASHA HD\u2122 technology, engineered to build and shape on bone for instant, natural-looking lower-face shaping from any angle1-3 It is the latest addition to the innovative Restylane portfolio \u2013 the world's most diverse range of hyaluronic acid injectables designed to meet evolving aesthetic needs, backed by three decades of science4 ZUG, Switzerland, August 11, 20", "url": "https://finance.yahoo.com/healthcare/articles/galderma-receives-european-union-approval-050000475.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-11T05:00:00+00:00", "published_display": "11 Aug 2026 05:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.344, "duplicate_count": 1, "topics": ["Aesthetic Treatments", "Dermatology", "Fda Approval", "Injectable Aesthetics"]}], "by_tier": {"direct": [{"title": "Galderma Receives European Union Approval for Restylane\u00ae Shaype\u2122: the First-and-Only Bone-Mimicking Hyaluronic Acid Injectable for Facial Shaping", "summary": "Galderma has introduced the first-and-only shaper to the hyaluronic acid (HA) market with Restylane Shaype, now approved in the European Union (EU) for chin augmentation1 Restylane Shaype is the firmest HA gel available, powered by new NASHA HD\u2122 technology, engineered to build and shape on bone for instant, natural-looking lower-face shaping from any angle1-3 It is the latest addition to the innovative Restylane portfolio \u2013 the world's most diverse range of hyaluronic acid injectables designed to meet evolving aesthetic needs, backed by three decades of science4 ZUG, Switzerland, August 11, 20", "url": "https://finance.yahoo.com/healthcare/articles/galderma-receives-european-union-approval-050000475.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-11T05:00:00+00:00", "published_display": "11 Aug 2026 05:00", "provider": "eodhd", "sentiment": "negative", "sentiment_pct": 34, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.344, "duplicate_count": 1, "topics": ["Aesthetic Treatments", "Dermatology", "Fda Approval", "Injectable Aesthetics"]}], "industry": [], "sector": []}, "total_fetched": 1, "total_unique": 1, "total_relevant": 1, "pipeline_health": {"providers_attempted": 1, "providers_with_results": 1, "provider_counts": {"eodhd": 1}, "raw_articles": 1, "unique_stories": 1, "duplicates_removed": 0, "relevant_stories": 1, "current_evidence": 1, "direct_evidence": 1, "eodhd_articles": 1, "eodhd": {"configured": true, "status": "healthy", "calls_used": 310, "call_budget": 500, "budget_used_pct": 62.0, "requests_made": 62, "last_success_at": "2026-08-13T11:15:16.589438+00:00", "newest_seen_at": "2026-08-13T11:03:51+00:00", "rate_limit": 1200, "rate_remaining": 1199, "last_error": "", "mapped_mentions": 3184, "unmapped_mentions": 1958}, "status": "healthy"}, "sentiment_summary": {"positive": 0, "negative": 1, "neutral": 0, "score": 45, "raw_score": 34, "total": 1, "evidence_count": 1, "effective_articles": 1.0, "direct_story_count": 1, "industry_story_count": 0, "sector_story_count": 0, "story_count": 1, "source_count": 1, "source_concentration": 1.0, "direct_share": 100, "dispersion": 0, "confidence": 42, "evidence_status": "measured", "score_version": "evidence-v4", "newest_article_at": "2026-08-11T05:00:00+00:00", "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "regulatory", "primary_label": "Regulatory and legal", "confidence": 72, "events": [{"event": "regulatory", "label": "Regulatory and legal", "weight": 0.6, "count": 1}], "positive_events": 0, "negative_events": 1, "pipeline": {"providers_attempted": 1, "providers_with_results": 1, "provider_counts": {"eodhd": 1}, "raw_articles": 1, "unique_stories": 1, "duplicates_removed": 0, "relevant_stories": 1, "current_evidence": 1, "direct_evidence": 1, "eodhd_articles": 1, "eodhd": {"configured": true, "status": "healthy", "calls_used": 310, "call_budget": 500, "budget_used_pct": 62.0, "requests_made": 62, "last_success_at": "2026-08-13T11:15:16.589438+00:00", "newest_seen_at": "2026-08-13T11:03:51+00:00", "rate_limit": 1200, "rate_remaining": 1199, "last_error": "", "mapped_mentions": 3184, "unmapped_mentions": 1958}, "status": "healthy"}}, "market_context": {"has_market_context": true, "latest_close": 181.35, "latest_week": "2026-08-07", "one_week_move": 3.2, "four_week_move": 4.9, "twelve_week_move": 15.8, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 0.825833, "market_dynamics_buy_signal": false, "relative_strength": 5.398709, "fair_value_gap": 54.7, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "positive", "expectation_probability": 67.0842, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+3.2% over one week, +4.9% over four weeks, trend active, and materially above fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 51, "badges": [], "opportunities": [], "risks": [], "event_label": "Regulatory and legal", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "finance.yahoo.com", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 1}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Regulatory and legal", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "45/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Evidence confidence", "value": "42/100", "tone": "neutral", "text": "1.0 effective stories after overlap and weighting."}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Regulatory and legal", "tone": "neutral", "text": "72/100 classification confidence."}, {"label": "Company focus", "value": "1", "tone": "neutral", "text": "100% of weighted evidence is company-specific."}, {"label": "Evidence agreement", "value": "0/100", "tone": "positive", "text": "lower dispersion means the independent stories agree more closely."}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "+3.2% over one week, +4.9% over four weeks, trend active, and materially above fair value."}, {"label": "Latest direct headline", "value": "Negative", "tone": "negative", "text": "Galderma Receives European Union Approval for Restylane\u00ae Shaype\u2122: the First-and-Only Bone-Mimicking Hyaluronic Acid Injectable for Facial Shaping"}], "updated_at": "2026-08-13T11:16:55.866388+00:00", "detail_intelligence": {"headline": "Balanced read", "summary": "Balanced news tone is drawn from 1 fresh independent stories, including 1 company-specific items across 1 publishers.", "status": "measured", "metrics": [{"label": "Weighted tone", "value": 45, "display": "45", "tone": "neutral", "note": "Balanced news tone"}, {"label": "Evidence confidence", "value": 42, "display": "42", "tone": "neutral", "note": "building confidence"}, {"label": "Company focus", "value": 100, "display": "100%", "tone": "positive", "note": "1 direct stories"}, {"label": "Evidence agreement", "value": 0, "display": "N/A", "tone": "neutral", "note": "requires at least 2 stories"}], "confidence_drivers": [{"label": "Sample depth", "value": 12, "note": "1.0 effective stories"}, {"label": "Source breadth", "value": 20, "note": "1 independent publishers"}, {"label": "Direct relevance", "value": 100, "note": "company-specific evidence share"}, {"label": "Freshness", "value": 68, "note": "recency-weighted evidence"}, {"label": "Agreement", "value": 0, "note": "requires at least 2 stories"}, {"label": "Source independence", "value": 0, "note": "lower publisher concentration"}], "freshness": 68, "source_independence": 0, "timeline": [{"date": "2026-07-24", "label": "24 Jul", "count": 0, "score": null, "tone": "neutral", "x": 42.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-25", "label": "25 Jul", "count": 0, "score": null, "tone": "neutral", "x": 87.8, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-26", "label": "26 Jul", "count": 0, "score": null, "tone": "neutral", "x": 133.6, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-27", "label": "27 Jul", "count": 0, "score": null, "tone": "neutral", "x": 179.4, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-28", "label": "28 Jul", "count": 0, "score": null, "tone": "neutral", "x": 225.2, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-29", "label": "29 Jul", "count": 0, "score": null, "tone": "neutral", "x": 271.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-30", "label": "30 Jul", "count": 0, "score": null, "tone": "neutral", "x": 316.8, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-31", "label": "31 Jul", "count": 0, "score": null, "tone": "neutral", "x": 362.6, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-01", "label": "01 Aug", "count": 0, "score": null, "tone": "neutral", "x": 408.4, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-02", "label": "02 Aug", "count": 0, "score": null, "tone": "neutral", "x": 454.2, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-03", "label": "03 Aug", "count": 0, "score": null, "tone": "neutral", "x": 500.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-04", "label": "04 Aug", "count": 0, "score": null, "tone": "neutral", "x": 545.8, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-05", "label": "05 Aug", "count": 0, "score": null, "tone": "neutral", "x": 591.6, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-06", "label": "06 Aug", "count": 0, "score": null, "tone": "neutral", "x": 637.4, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-07", "label": "07 Aug", "count": 0, "score": null, "tone": "neutral", "x": 683.2, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-08", "label": "08 Aug", "count": 0, "score": null, "tone": "neutral", "x": 729.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-09", "label": "09 Aug", "count": 0, "score": null, "tone": "neutral", "x": 774.8, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-10", "label": "10 Aug", "count": 0, "score": null, "tone": "neutral", "x": 820.6, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-11", "label": "11 Aug", "count": 1, "score": 34, "tone": "negative", "x": 866.4, "y": 164.1, "volume_height": 52.0, "volume_y": 214.0}, {"date": "2026-08-12", "label": "12 Aug", "count": 0, "score": null, "tone": "neutral", "x": 912.2, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-13", "label": "13 Aug", "count": 0, "score": null, "tone": "neutral", "x": 958.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}], "timeline_points": "866.4,164.1", "timeline_has_signal": true, "timeline_start": "24 Jul", "timeline_mid": "03 Aug", "timeline_end": "13 Aug", "momentum": {"label": "Establishing", "tone": "neutral", "recent_score": 34, "prior_score": null, "delta": null, "recent_count": 1, "prior_count": 0, "volume_delta": 1}, "freshness_buckets": [{"label": "Last 24 hours", "count": 0, "share": 0}, {"label": "1 to 3 days", "count": 1, "share": 100}, {"label": "4 to 7 days", "count": 0, "share": 0}, {"label": "8 to 30 days", "count": 0, "share": 0}], "source_profile": [{"label": "finance.yahoo.com", "count": 1, "share": 100, "score": 34, "tone": "negative"}], "event_profile": [{"label": "Regulatory and legal", "count": 1, "share": 100, "score": 34, "tone": "negative"}], "topics": [{"label": "Injectable Aesthetics", "count": 1, "share": 100}, {"label": "Fda Approval", "count": 1, "share": 100}, {"label": "Dermatology", "count": 1, "share": 100}, {"label": "Aesthetic Treatments", "count": 1, "share": 100}], "supporting": [{"label": "Direct evidence", "text": "1 current stories are mapped specifically to GALD."}], "tempering": [{"label": "Source breadth", "text": "Only 1 publisher currently contribute to the measured read."}], "supporting_heading": "What supports the read", "tempering_heading": "What tempers the read", "latest_observation": {"title": "Galderma Receives European Union Approval for Restylane\u00ae Shaype\u2122: the First-and-Only Bone-Mimicking Hyaluronic Acid Injectable for Facial Shaping", "summary": "Galderma has introduced the first-and-only shaper to the hyaluronic acid (HA) market with Restylane Shaype, now approved in the European Union (EU) for chin augmentation1 Restylane Shaype is the firmest HA gel available, powered by new NASHA HD\u2122 technology, engineered to build and shape on bone for instant, natural-looking lower-face shaping from any angle1-3 It is the latest addition to the innovative Restylane portfolio \u2013 the world's most diverse range of hyaluronic acid injectables designed to meet evolving aesthetic needs, backed by three decades of science4 ZUG, Switzerland, August 11, 20", "url": "https://finance.yahoo.com/healthcare/articles/galderma-receives-european-union-approval-050000475.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-11T05:00:00+00:00", "published_display": "11 Aug 2026 05:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.347, "duplicate_count": 1, "topics": ["Aesthetic Treatments", "Dermatology", "Fda Approval", "Injectable Aesthetics"]}, "article_count": 1, "updated_at": "2026-08-13T10:00:15.787981+00:00"}, "price_sentiment_path": {"available": true, "price_points": [{"x": 42.0, "y": 166.4, "label": "13 Feb 2026", "close": 151.87, "index": 100.0}, {"x": 78.6, "y": 158.9, "label": "20 Feb 2026", "close": 153.86, "index": 101.3}, {"x": 115.3, "y": 190.0, "label": "27 Feb 2026", "close": 145.58, "index": 95.9}, {"x": 151.9, "y": 152.2, "label": "06 Mar 2026", "close": 155.66, "index": 102.5}, {"x": 188.6, "y": 197.8, "label": "13 Mar 2026", "close": 143.49, "index": 94.5}, {"x": 225.2, "y": 204.2, "label": "20 Mar 2026", "close": 141.79, "index": 93.4}, {"x": 261.8, "y": 176.1, "label": "27 Mar 2026", "close": 149.27, "index": 98.3}, {"x": 298.5, "y": 150.3, "label": "03 Apr 2026", "close": 156.16, "index": 102.8}, {"x": 335.1, "y": 137.9, "label": "10 Apr 2026", "close": 159.45, "index": 105.0}, {"x": 371.8, "y": 149.0, "label": "17 Apr 2026", "close": 156.51, "index": 103.1}, {"x": 408.4, "y": 127.1, "label": "24 Apr 2026", "close": 162.35, "index": 106.9}, {"x": 445.0, "y": 121.6, "label": "01 May 2026", "close": 163.8, "index": 107.9}, {"x": 481.7, "y": 121.3, "label": "08 May 2026", "close": 163.9, "index": 107.9}, {"x": 518.3, "y": 148.5, "label": "15 May 2026", "close": 156.65, "index": 103.1}, {"x": 555.0, "y": 141.0, "label": "22 May 2026", "close": 158.65, "index": 104.5}, {"x": 591.6, "y": 111.3, "label": "29 May 2026", "close": 166.55, "index": 109.7}, {"x": 628.2, "y": 130.3, "label": "05 Jun 2026", "close": 161.5, "index": 106.3}, {"x": 664.9, "y": 90.3, "label": "12 Jun 2026", "close": 172.15, "index": 113.4}, {"x": 701.5, "y": 89.4, "label": "19 Jun 2026", "close": 172.4, "index": 113.5}, {"x": 738.2, "y": 67.4, "label": "26 Jun 2026", "close": 178.25, "index": 117.4}, {"x": 774.8, "y": 62.6, "label": "03 Jul 2026", "close": 179.55, "index": 118.2}, {"x": 811.4, "y": 87.7, "label": "10 Jul 2026", "close": 172.85, "index": 113.8}, {"x": 848.1, "y": 89.0, "label": "17 Jul 2026", "close": 172.5, "index": 113.6}, {"x": 884.7, "y": 84.7, "label": "24 Jul 2026", "close": 173.65, "index": 114.3}, {"x": 921.4, "y": 76.8, "label": "31 Jul 2026", "close": 175.75, "index": 115.7}, {"x": 958.0, "y": 55.8, "label": "07 Aug 2026", "close": 181.35, "index": 119.4}], "sentiment_points": [{"x": 709.0, "y": 124.5, "label": "20 Jun 2026", "score": 53}, {"x": 712.4, "y": 122.6, "label": "21 Jun 2026", "score": 54}, {"x": 713.1, "y": 122.6, "label": "21 Jun 2026", "score": 54}, {"x": 720.9, "y": 120.8, "label": "22 Jun 2026", "score": 55}, {"x": 721.2, "y": 120.8, "label": "22 Jun 2026", "score": 55}, {"x": 726.8, "y": 119.0, "label": "23 Jun 2026", "score": 56}, {"x": 733.4, "y": 119.0, "label": "25 Jun 2026", "score": 56}, {"x": 739.8, "y": 120.8, "label": "26 Jun 2026", "score": 55}, {"x": 742.9, "y": 117.1, "label": "26 Jun 2026", "score": 57}, {"x": 744.6, "y": 117.1, "label": "27 Jun 2026", "score": 57}, {"x": 756.8, "y": 122.6, "label": "29 Jun 2026", "score": 54}, {"x": 765.2, "y": 122.6, "label": "01 Jul 2026", "score": 54}, {"x": 767.1, "y": 122.6, "label": "01 Jul 2026", "score": 54}, {"x": 772.9, "y": 126.3, "label": "02 Jul 2026", "score": 52}, {"x": 775.2, "y": 124.5, "label": "03 Jul 2026", "score": 53}, {"x": 776.5, "y": 122.6, "label": "03 Jul 2026", "score": 54}, {"x": 780.0, "y": 124.5, "label": "03 Jul 2026", "score": 53}, {"x": 781.2, "y": 124.5, "label": "04 Jul 2026", "score": 53}, {"x": 799.8, "y": 131.8, "label": "07 Jul 2026", "score": 49}, {"x": 801.8, "y": 130.0, "label": "08 Jul 2026", "score": 50}, {"x": 816.0, "y": 131.8, "label": "10 Jul 2026", "score": 49}, {"x": 832.0, "y": 126.3, "label": "13 Jul 2026", "score": 52}, {"x": 845.3, "y": 126.3, "label": "16 Jul 2026", "score": 52}, {"x": 854.6, "y": 126.3, "label": "18 Jul 2026", "score": 52}, {"x": 864.5, "y": 120.8, "label": "20 Jul 2026", "score": 55}, {"x": 879.8, "y": 126.3, "label": "23 Jul 2026", "score": 52}, {"x": 881.2, "y": 126.3, "label": "23 Jul 2026", "score": 52}, {"x": 881.4, "y": 126.3, "label": "23 Jul 2026", "score": 52}, {"x": 882.1, "y": 126.3, "label": "23 Jul 2026", "score": 52}, {"x": 883.1, "y": 130.0, "label": "23 Jul 2026", "score": 50}, {"x": 911.6, "y": 120.8, "label": "29 Jul 2026", "score": 55}, {"x": 922.2, "y": 122.6, "label": "31 Jul 2026", "score": 54}, {"x": 935.9, "y": 120.8, "label": "02 Aug 2026", "score": 55}, {"x": 948.2, "y": 124.5, "label": "05 Aug 2026", "score": 53}], "price_path": "42.0,166.4 78.6,158.9 115.3,190.0 151.9,152.2 188.6,197.8 225.2,204.2 261.8,176.1 298.5,150.3 335.1,137.9 371.8,149.0 408.4,127.1 445.0,121.6 481.7,121.3 518.3,148.5 555.0,141.0 591.6,111.3 628.2,130.3 664.9,90.3 701.5,89.4 738.2,67.4 774.8,62.6 811.4,87.7 848.1,89.0 884.7,84.7 921.4,76.8 958.0,55.8", "sentiment_path": "709.0,124.5 712.4,122.6 713.1,122.6 720.9,120.8 721.2,120.8 726.8,119.0 733.4,119.0 739.8,120.8 742.9,117.1 744.6,117.1 756.8,122.6 765.2,122.6 767.1,122.6 772.9,126.3 775.2,124.5 776.5,122.6 780.0,124.5 781.2,124.5 799.8,131.8 801.8,130.0 816.0,131.8 832.0,126.3 845.3,126.3 854.6,126.3 864.5,120.8 879.8,126.3 881.2,126.3 881.4,126.3 882.1,126.3 883.1,130.0 911.6,120.8 922.2,122.6 935.9,120.8 948.2,124.5", "price_change": 19.4, "sentiment_change": 0, "latest_close": 181.35, "start_label": "13 Feb", "mid_label": "15 May", "end_label": "07 Aug"}, "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}